Fifth Third Bancorp Uni Qure N.V. Transaction History

Fifth Third Bancorp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$6.71 - $11.83 $301 - $532	-45 Reduced 16.36%	230 $1,000
Q2 2022 Aug 04, 2022	BUY	$13.15 - $20.45 $3,616 - $5,623	275 New	275 $5,000
Q1 2022 Apr 19, 2022	SELL	$14.54 - $21.5 $857 - $1,268	-59 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$20.24 - $36.01 $1,679 - $2,988	-83 Reduced 58.45%	59 $1,000
Q3 2021 Oct 15, 2021	BUY	$26.01 - $38.22 $1,560 - $2,293	60 Added 73.17%	142 $5,000
Q2 2021 Aug 06, 2021	SELL	$29.97 - $37.17 $1,108 - $1,375	-37 Reduced 31.09%	82 $3,000
Q1 2021 May 07, 2021	SELL	$29.24 - $42.03 $12,017 - $17,274	-411 Reduced 77.55%	119 $4,000
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $109,054 - $156,316	-3,085 Reduced 85.34%	530 $19,000
Q3 2020 Nov 09, 2020	BUY	$35.98 - $47.66 $130,067 - $172,290	3,615 New	3,615 $133,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.